Anzeige
Mehr »
Sonntag, 05.10.2025 - Börsentäglich über 12.000 News
Innocan Pharma: Neues Medikament für den Massenmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PV0Q | ISIN: CA87975M2085 | Ticker-Symbol: 3D0A
Tradegate
01.10.25 | 16:12
0,036 Euro
-19,10 % -0,009
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TELO GENOMICS CORP Chart 1 Jahr
5-Tage-Chart
TELO GENOMICS CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0420,04904.10.
0,0420,04703.10.

Aktuelle News zur TELO GENOMICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiTelo Genomics Corp (2): Telo Genomics relocates clinical laboratories2
TELO GENOMICS Aktie jetzt für 0€ handeln
DiTelo Genomics Corp.: Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update367Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for...
► Artikel lesen
DiTelo Genomics Corp (2): Telo Genomics 411,539 shares for debt3
19.09.Telo Genomics Corp.: Telo Genomics Highlights New MRD Methodology at The 2025 International Myeloma Society Meeting302Toronto, Ontario--(Newsfile Corp. - September 19, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for...
► Artikel lesen
08.09.Telo Genomics Corp.: Telo Geonomics Announces Engagement of Investor Relations Service Provider446Vancouver, British Columbia--(Newsfile Corp. - September 8, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") announces that it has engaged Hayden IR, LLC....
► Artikel lesen
05.08.Telo Genomics Corp.: Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference468Toronto, Ontario--(Newsfile Corp. - August 5, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
24.07.Telo Genomics Corp.: International Myeloma Society Accepts Telo Genomics' MRD Abstract for Presentation at Its 2025 Meeting375Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
01.07.Telo Genomics Corp (2): Telo Genomics used by ex-president Louis over bonuses8
01.07.Telo Genomics Corp. to File Statement of Defence and Counterclaim to Lawsuit Filed by Former President369Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") has received a Statement of Claim filed by Sherif Louis, the...
► Artikel lesen
19.06.Telo Genomics Corp (2): Telo Genomics begins multiple myeloma clinical trial1
18.06.Telo Genomics Corp.: Telo Genomics Initiate Clinical Trial for Minimal Residual Disease in Multiple Myeloma426Toronto, Ontario--(Newsfile Corp. - June 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
28.05.Telo Genomics Corp (2): Telo Genomics enters client agreement with IPON4
27.05.Telo Genomics Corp.: Telo Genomics Receives New Client Tier under Intellectual Property Ontario (IPON)395Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
15.05.Telo Genomics Corp.: European Hematology Association Accepts Abstract from Telo Genomics for Presentation at The 2025 Congress496Toronto, Ontario--(Newsfile Corp. - May 15, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
10.04.Telo Genomics Corp.: Telo Genomics Announces Acceptance of its MRD Validation Data in Multiple Myeloma for ASCO 2025563Toronto, Ontario--(Newsfile Corp. - April 10, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
04.04.Telo Genomics Corp.: Telo Genomics Announces Appointment of John Farlinger to Its Board of Directors413Toronto, Ontario--(Newsfile Corp. - April 4, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tests...
► Artikel lesen
12.03.Telo Genomics Corp.: Telo Genomics Appoints Baechler Executive Chairman of The Board of Directors388Toronto, Ontario--(Newsfile Corp. - March 12, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tests...
► Artikel lesen
27.02.Telo Genomics Corp.: Telo Genomics Announces Expanded Partnership with Trusted Health Advisors570Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") announces that, further to its engagement with Trusted Health...
► Artikel lesen
23.12.24Telo Genomics Corp.: Telo Genomics Closes Oversubscribed $2.5 Million Private Placement718Toronto, Ontario--(Newsfile Corp. - December 23, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA) (the "Company" or "Telo") is pleased to announce that, further to its news release...
► Artikel lesen
12.12.24Telo Genomics Corp.: Telo Genomics Announces Private Placement for up to $2 Million662Toronto, Ontario--(Newsfile Corp. - December 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA) (the "Company" or "Telo") is pleased to announce a non-brokered private placement...
► Artikel lesen
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1